HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NutraMax

This article was originally published in The Tan Sheet

Executive Summary

Chapter 11 bankruptcy terms confirmed, Gloucester, Mass.-based marketer announces Nov. 7, enabling shareholders to purchase new stock in the reorganized company. Capital raised by offering will go to pay off $18 mil. debt. Company increases debt to CIT Group/Business Credit from $30 mil. to $40 mil. to maintain operations; the bankruptcy plan was submitted to Wilmington, Del. federal court in May (1"The Tan Sheet" May 22, p. 5)

You may also be interested in...



Former NutraMax Execs Misstated Financials, Class Action Lawsuit Alleges

Two former NutraMax executives materially misstated the OTC private labeler's revenues, income and earnings from January 1998 to November 1999, shareholders allege in a class action lawsuit filed May 15 in Boston federal court.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133308

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel